ANTIBODY-MEDIATED PROTECTION IN MICE WITH LETHAL INTRACEREBRAL CRYPTOCOCCUS NEOFORMANS INFECTION

被引:90
作者
MUKHERJEE, J
PIROFSKI, LA
SCHARFF, MD
CASADEVALL, A
机构
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT CELL BIOL,1300 MORRIS PK AVE,BRONX,NY 10461
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,DIV INFECT DIS,BRONX,NY 10461
[3] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MICROBIOL & IMMUNOL,BRONX,NY 10461
关键词
MONOCLONAL ANTIBODY; BLOOD-BRAIN BARRIER; FUNGUS;
D O I
10.1073/pnas.90.8.3636
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The fungus Cryptococcus neoformans is an important opportunistic pathogen for patients with AIDS. C. neoformans infections frequently involve the brain and are often fatal. In the setting of AIDS C. neoformans infections are incurable and new treatment strategies are urgently needed. Passive administration of antibody is a potential therapeutic option for the prevention and treatment of C. neoformans. The IgG1 murine monoclonal antibody 2H1 to the capsular polysaccharide of C. neoformans was studied for its ability to modify the course of lethal intracerebral cryptococcal infection in mice. Intraperitoneal administration of antibody 2H1 resulted in small, yet significant, prolongations in the average survival of mice given intracerebral infection and reduced the number of C. neoformans colonies in brain tissue. Histopathological examination of brain tissues revealed a diffuse cryptococcal meningitis with fewer organisms in the brains of mice that received antibody 2H1 than in the control group. Thus, systemic administration of a monoclonal antibody can modify the course of lethal intracerebral C. neoformans infection in mice by prolonging survival and decreasing fungal burden in brain tissues.
引用
收藏
页码:3636 / 3640
页数:5
相关论文
共 76 条
[41]  
KAO CJ, 1957, AM J CLIN PATHOL, V27, P652
[42]  
KOZEL TR, 1988, REV INFECT DIS, V10, pS436
[43]   OPSONIZATION OF CRYPTOCOCCUS-NEOFORMANS BY HUMAN IMMUNOGLOBULIN-G - ROLE OF IMMUNOGLOBULIN-G IN PHAGOCYTOSIS BY MACROPHAGES [J].
KOZEL, TR ;
MCGAW, TG .
INFECTION AND IMMUNITY, 1979, 25 (01) :255-261
[44]   IMMUNE-RESPONSE TO CRYPTOCOCCUS-NEOFORMANS SOLUBLE POLYSACCHARIDE .1. SEROLOGICAL ASSAY FOR ANTIGEN AND ANTIBODY [J].
KOZEL, TR ;
CAZIN, J .
INFECTION AND IMMUNITY, 1972, 5 (01) :35-&
[45]   OPSONIZATION OF ENCAPSULATED CRYPTOCOCCUS-NEOFORMANS BY SPECIFIC ANTI-CAPSULAR ANTIBODY [J].
KOZEL, TR ;
FOLLETTE, JL .
INFECTION AND IMMUNITY, 1981, 31 (03) :978-984
[46]  
KOZEL TR, 1982, J IMMUNOL, V129, P1675
[47]   IMMUNE-RESPONSE TO CRYPTOCOCCUS-NEOFORMANS SOLUBLE POLYSACCHARIDE - IMMUNOLOGICAL-UNRESPONSIVENESS [J].
KOZEL, TR ;
GULLEY, WF ;
CAZIN, J .
INFECTION AND IMMUNITY, 1977, 18 (03) :701-707
[48]   EARLY EVENTS IN INITIATION OF ALTERNATIVE COMPLEMENT PATHWAY ACTIVATION BY THE CAPSULE OF CRYPTOCOCCUS-NEOFORMANS [J].
KOZEL, TR ;
WILSON, MA ;
MURPHY, JW .
INFECTION AND IMMUNITY, 1991, 59 (09) :3101-3110
[49]  
Kwon-Chung, 1992, MED MYCOL, P397
[50]   ENCAPSULATION AND MELANIN FORMATION AS INDICATORS OF VIRULENCE IN CRYPTOCOCCUS-NEOFORMANS [J].
KWONCHUNG, KJ ;
RHODES, JC .
INFECTION AND IMMUNITY, 1986, 51 (01) :218-223